Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Researchers made two new compounds that could be used for medicine.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

Blocking progesterone metabolism can cause depression-like behavior in mice.

FGF-2&D/P nanoparticles can help treat hair loss.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Progesterone helps protect against stress-related memory and behavior issues in rats.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.